HR2935-119

In Committee

PREPARE Act of 2025

119th Congress Introduced Apr 17, 2025

Summary

What This Bill Does

The PREPARE Act does not legalize cannabis directly. It creates a Commission on the Federal Regulation of Cannabis inside the Department of Justice to prepare the federal government for a possible end to federal marijuana prohibition. The commission must study a pathway to cannabis regulation modeled on alcohol regulation and recommend ways to address criminalization harms, access to financial services for cannabis entrepreneurs, research barriers, medical cannabis access, product safety and labeling, youth protection, revenue collection, crop production, interstate and international trade, and coexistence of hemp and cannabis industries. It must solicit public comment within 60 days, convene witness hearings within 180 days including state-licensed cannabis operators and people incarcerated for nonviolent cannabis offenses, publish initial recommendations at 120 days, and publish a final report within one year.

Who Benefits and How

State cannabis regulators benefit because the commission is designed to learn from state regulatory systems and identify federal-state coordination barriers. Cannabis entrepreneurs benefit because access to banking, revenue reporting, product rules, and interstate trade barriers are explicit study topics. Medical cannabis patients benefit because the commission must examine medical access, research, medical training, and affordable treatment options. Minority communities affected by cannabis criminalization benefit because the bill requires attention to criminalization impacts and appoints members with that expertise.

Who Bears the Burden and How

The Department of Justice must establish and staff the commission, handle missed appointments, collect comments, and publish recommendations. Federal agencies named for membership must supply senior officials or experts from health, tax, agriculture, labor, education, housing, commerce, and drug-control offices. Commission members must attend quarterly meetings and can face review after two absences in a year. Cannabis opponents may face a formal federal planning process premised on eventual post-prohibition regulation.

Key Provisions

  • Creates the Commission on the Federal Regulation of Cannabis within the Department of Justice.
  • Requires study of banking, research, medical access, product safety, youth protection, revenue, crop, trade, hemp, and equity barriers.
  • Requires public comment, witness hearings, initial recommendations after 120 days, and a final report within one year.
  • Establishes commission membership across Congress, DOJ, ATF, NHTSA, Education, OSHA, USDA, FDA, IRS, USTR, Commerce, HHS, NIH, VA, SBA, NIST, HUD, Labor, Treasury, ONDCP, OMH, IHS, industry, and state regulators.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Establishes a Department of Justice Commission on the Federal Regulation of Cannabis to recommend an alcohol-modeled federal cannabis regulatory framework, solicit public input, hold industry and criminal-justice hearings, and publish initial and final recommendations within one year.

Key Policy Areas

Cannabis, Criminal Justice, Public Health, Regulation

Primary Purpose

Establishes a Department of Justice Commission on the Federal Regulation of Cannabis to recommend an alcohol-modeled federal cannabis regulatory framework, solicit public input, hold industry and criminal-justice hearings, and publish initial and final recommendations within one year.

Policy Domains

Cannabis Criminal Justice Public Health Regulation

Resolution provisions

Identified Gains
  • State cannabis regulators
  • Cannabis entrepreneurs
  • Medical cannabis patients
  • Minority communities affected by cannabis criminalization
  • Veteran cannabis patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Cannabis entrepreneurs: , ,
Medical cannabis patients: , ,
State cannabis regulators: , ,
Veteran cannabis patients: , ,
Minority communities affected by cannabis criminalization: , ,
Identified Costs
  • Department of Justice
  • Federal agency commission members
  • Commission members
  • Cannabis opponents
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Cannabis opponents: , ,
Commission members: , ,
Department of Justice: , ,
Federal agency commission members: , ,

Legislative Progress

In Committee
Introduced Committee Passed
Apr 17, 2025

Mr. Joyce of Ohio (for himself, Mr. Jeffries, and Mr. …

Apr 17, 2025

Referred to the Committee on Energy and Commerce, and in …

Apr 17, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
9 mentions across 3 clauses
+3 positive -6 negative

Department of Justice, Federal agency commission members, State cannabis regulators

Positive-direction: State cannabis regulators

Negative-direction: Department of Justice, Federal agency commission members

Small Business
3 mentions across 3 clauses
+3 positive

Cannabis entrepreneurs

Healthcare
3 mentions across 3 clauses
+3 positive

Medical cannabis patients

Advocacy Groups
3 mentions across 3 clauses
+3 positive

Minority communities affected by cannabis criminalization

3/4
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Cannabis Criminal Justice Public Health Regulation

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology